Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node-Reference-Cited by-同舟云学术

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node

Published:2018-11-21 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Houvenaeghel Gilles, ,Cohen Monique,Raro Pédro,De Troyer Jérémy,de Lara Christine Tunon,Gimbergues Pierre,Gauthier Tristan,Faure-Virelizier Christelle,Vaini-Cowen Véronique,Lantheaume Stéphane,Regis Claudia,Darai Emile,Ceccato Vivien,D’Halluin Gauthier,Del Piano Francesco,Villet Richard,Jouve Eva,Beedassy Bassoodéo,Theret Pierrick,Gabelle Philippe,Zinzindohoue Cécile,Opinel Pierre,Marsollier-Ferrer Catherine,Dhainaut-Speyer Caroline,Colombo Pierre-Emmanuel,Lambaudie Eric,Tallet Agnès,Boher Jean-Marie

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-5053-7.pdf

Reference27 articles.

1. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–53.

2. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251:595–600.

3. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.

4. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20.

5. Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C, Charytansky H, Rouzier R, Daraï E, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Fraisse J, Dravet F, Chauvet MP, Goncalves A, Lambaudie E. Survival impact and predictive factors of axillary recurrence after sentinel biopsy. Eur J Cancer. 2016;58:73–82.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postoperative Outcomes of Pre-Pectoral Versus Sub-Pectoral Implant Immediate Breast Reconstruction;Cancers;2024-03-12

2. Radiothérapie des cancers du sein : questions d’actualité en 2023;Cancer/Radiothérapie;2023-09

3. The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases;Cancer Medicine;2022-09-20

4. Intraoperative prediction of non‑sentinel lymph node metastases in breast cancer using cytokeratin 19 mRNA copy number: A retrospective analysis;Molecular and Clinical Oncology;2022-01-10

5. Impact of Post-Mastectomy Radiation Therapy for Sentinel Lymph Node Micrometastases in Early-Stage Breast Cancer Patients;Medical Science Monitor;2021-10-25